These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 16720652

  • 1. Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency.
    Bidlingmaier M, Kim J, Savoy C, Kim MJ, Ebrecht N, de la Motte S, Strasburger CJ.
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2926-30. PubMed ID: 16720652
    [Abstract] [Full Text] [Related]

  • 2. Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency.
    Biller BM, Ji HJ, Ahn H, Savoy C, Siepl EC, Popovic V, Coculescu M, Roemmler J, Gavrila C, Cook DM, Strasburger CJ.
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1718-26. PubMed ID: 21411551
    [Abstract] [Full Text] [Related]

  • 3. Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD).
    Péter F, Bidlingmaier M, Savoy C, Ji HJ, Saenger PH.
    J Clin Endocrinol Metab; 2012 Feb; 97(2):400-7. PubMed ID: 22162481
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency.
    Peter F, Savoy C, Ji HJ, Juhasz M, Bidlingmaier M, Saenger P.
    Eur J Endocrinol; 2009 Mar; 160(3):349-55. PubMed ID: 19074465
    [Abstract] [Full Text] [Related]

  • 5. 24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency.
    Khadilkar V, Radjuk KA, Bolshova E, Khadgawat R, El Kholy M, Desai M, Peterkova V, Mericq V, Kratzsch J, Siepl EC, Martin D, Lopez P, Ji HJ, Bae YJ, Lee JH, Saenger PH.
    J Clin Endocrinol Metab; 2014 Jan; 99(1):126-32. PubMed ID: 24170106
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency.
    Hwang JS, Lee HS, Chung WY, Han HS, Jin DK, Kim HS, Ko CW, Lee BC, Lee DY, Lee KH, Shin JH, Suh BK, Yoo HW, Ji HJ, Lee JH, Bae YJ, Kim DH, Yang SW.
    Eur J Endocrinol; 2013 Aug; 169(2):179-85. PubMed ID: 23682096
    [Abstract] [Full Text] [Related]

  • 7. Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency.
    Rasmussen MH, Janukonyté J, Klose M, Marina D, Tanvig M, Nielsen LF, Höybye C, Andersen M, Feldt-Rasmussen U, Christiansen JS.
    J Clin Endocrinol Metab; 2016 Mar; 101(3):988-98. PubMed ID: 26727076
    [Abstract] [Full Text] [Related]

  • 8. 12-month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency.
    Biller BM, Ji HJ, Ahn H, Savoy C, Siepl EC, Popovic V, Coculescu M, Roemmler J, Gavrila C, Cook DM, Strasburger CJ.
    Pituitary; 2013 Sep; 16(3):311-8. PubMed ID: 22915288
    [Abstract] [Full Text] [Related]

  • 9. Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiency.
    Roemmler J, Gockel A, Otto B, Bidlingmaier M, Schopohl J.
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):88-95. PubMed ID: 21682757
    [Abstract] [Full Text] [Related]

  • 10. A new sustained-release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile.
    Jostel A, Mukherjee A, Alenfall J, Smethurst L, Shalet SM.
    Clin Endocrinol (Oxf); 2005 May; 62(5):623-7. PubMed ID: 15853836
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: A randomized dose-escalation trial.
    Battelino T, Rasmussen MH, De Schepper J, Zuckerman-Levin N, Gucev Z, Sävendahl L, NN8640-4042 Study Group.
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):350-358. PubMed ID: 28656605
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [Abstract] [Full Text] [Related]

  • 17. A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency.
    Chatelain P, Malievskiy O, Radziuk K, Senatorova G, Abdou MO, Vlachopapadopoulou E, Skorodok Y, Peterkova V, Leff JA, Beckert M, TransCon GH Working Group.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1673-1682. PubMed ID: 28201598
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.
    Kemp SF, Fielder PJ, Attie KM, Blethen SL, Reiter EO, Ford KM, Marian M, Dao LN, Lee HJ, Saenger P.
    J Clin Endocrinol Metab; 2004 Jul 01; 89(7):3234-40. PubMed ID: 15240597
    [Abstract] [Full Text] [Related]

  • 19. A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile.
    Rasmussen MH, Olsen MW, Alifrangis L, Klim S, Suntum M.
    J Clin Endocrinol Metab; 2014 Oct 01; 99(10):E1819-29. PubMed ID: 25013997
    [Abstract] [Full Text] [Related]

  • 20. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
    Bevan JS, Atkin SL, Atkinson AB, Bouloux PM, Hanna F, Harris PE, James RA, McConnell M, Roberts GA, Scanlon MF, Stewart PM, Teasdale E, Turner HE, Wass JA, Wardlaw JM.
    J Clin Endocrinol Metab; 2002 Oct 01; 87(10):4554-63. PubMed ID: 12364434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.